Aurobindo Pharma: Will the medicine work this time???
Updated
Aurobindo
Observations
- has been sideways since May 16, 2022
- stock has moved past 20 day EMA
- stock has crossed 50 day EMA
- the stock is on the verge of breaking range bound channel
- sustaining above 552 is going to be the key
-target for the set up 612 / 630
Consider buying 570 Call Option at cmp & /or on dips in Spot Aurobindo Pharma around 552
Target 33 / 42
Do proper risk management
Disclaimer
- The view expressed here is my personal view
- Past performance is not a guarantee for future predictions
- Use this for educational purpose
- Any decision you take, you need to take responsibility for the same
- It's your hard earned money. Treat it wisely
- Trade / Invest keeping in mind your trading style, goals and objectives, time horizon & risk tolerance
- if trading in F&O, understand that F&O trading involves risk
- Do take proper risk management measures
- Do your own analysis and consult your financial adviser if need be
Observations
- has been sideways since May 16, 2022
- stock has moved past 20 day EMA
- stock has crossed 50 day EMA
- the stock is on the verge of breaking range bound channel
- sustaining above 552 is going to be the key
-target for the set up 612 / 630
Consider buying 570 Call Option at cmp & /or on dips in Spot Aurobindo Pharma around 552
Target 33 / 42
Do proper risk management
Disclaimer
- The view expressed here is my personal view
- Past performance is not a guarantee for future predictions
- Use this for educational purpose
- Any decision you take, you need to take responsibility for the same
- It's your hard earned money. Treat it wisely
- Trade / Invest keeping in mind your trading style, goals and objectives, time horizon & risk tolerance
- if trading in F&O, understand that F&O trading involves risk
- Do take proper risk management measures
- Do your own analysis and consult your financial adviser if need be
Trade active
The stock has come to 50 day EMA
As suggested above
Have Bought 570 Call Option
Take care & safe trading...!!!
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.